Target Name: EPSTI1
NCBI ID: G94240
Other Name(s): epithelial stromal interaction 1 (breast) | BRESI1 | Epithelial stromal interaction 1 | Epithelial stromal interaction 1, transcript variant 1 | EPSTI1 variant 1 | ESIP1_HUMAN | epithelial stromal interaction 1 | Epithelial-stromal interaction protein 1 (isoform 1) | MGC29634 | Epithelial-stromal interaction protein 1

EPSTI1: A Potential Drug Target for Breast Diseases

Epithelial-stromal interaction (ESI) is a critical process that occurs between epithelial and stromal cells in various body tissues, including the breast. ESI plays a vital role in tissue repair, regeneration, and plasticity, and is closely associated with various diseases, including cancer, fibrosis, and wound healing. The understanding of ESI has significant implications for the development of new therapeutic approaches for these diseases.

EPSTI1: A Potential Drug Target and Biomarker

EPSTI1, also known as breast epithelial-stromal interaction gene 1, is a gene that encodes a protein involved in ESI. The protein produced by EPSTI1 has been shown to play a critical role in promoting ESI between epithelial and stromal cells, which is essential for tissue repair and regeneration.

Recent studies have suggested that EPSTI1 may be a potential drug target for various breast diseases, including breast cancer, fibrosis, and wound healing. By targeting the expression and function of EPSTI1, researchers may be able to develop new treatments for these diseases.

Targeting EPSTI1: A novel therapeutic approach

The identification of EPSTI1 as a potential drug target has significant implications for the development of new therapeutic approaches for breast diseases. By blocking the activity of EPSTI1, researchers may be able to inhibit the growth and progression of cancer cells, reduce fibrosis, and promote wound healing.

One potential approach to targeting EPSTI1 is through the use of small interfering RNA (siRNA). SiRNA is a natural form of RNA that can be used to interfere with the translation of protein genes into functional proteins. By using siRNA to reduce the expression of EPSTI1, researchers may be able to inhibit its activity and reduce the growth and progression of cancer cells.

Another potential approach to targeting EPSTI1 is through the use of monoclonal antibodies (mAb). MAb is a laboratory-produced antibody that can be used to target specific proteins with high affinity. By using mAb to targetEPSTI1, researchers may be able to inhibit its activity and reduce the growth and progression of cancer cells.

Expression of EPSTI1 in breast tissue

To understand the expression of EPSTI1 in breast tissue, researchers have conducted various experiments, including transcriptomic analysis and immunohistochemical analysis. These studies have shown that EPSTI1 is expressed in breast tissue and plays a critical role in ESI between epithelial and stromal cells.

Immunohistochemical analysis of breast tissue has shown that EPSTI1 is a protein that is expressed in the epithelial tissue of the breast, and is located in the cytoplasm of these cells. The expression of EPSTI1 has also been shown to be regulated by various factors, including TGF-β, Wnt, and hedgehog.

Transcriptomic analysis of breast tissue has shown thatEPSTI1 is expressed at various levels in breast tissue, and plays a critical role in the regulation of cell growth, apoptosis, and angiogenesis. These studies suggest that EPSTI1 is a key player in the regulation of breast tissue homeostasis and that its dysfunction may be involved in the development of various breast diseases.

The potential implications ofEPSTI1 as a drug target

The identification ofEPSTI1 as a potential drug target has significant implications for the development of new therapeutic approaches for breast diseases. By targeting the expression and function of EPSTI1, researchers may be able to inhibit its activity and reduce the growth and progression of cancer cells, leading to a reduction in the risk of breast cancer.

EPSTI1 has also been shown to play a critical role in the regulation of cell growth, apoptosis, and angiogenesis, which may make it an attractive target for drugs that are aimed at

Protein Name: Epithelial Stromal Interaction 1

Functions: Plays a role in M1 macrophage polarization and is required for the proper regulation of gene expression during M1 versus M2 macrophage differentiation (By similarity). Might play a role in RELA/p65 and STAT1 phosphorylation and nuclear localization upon activation of macrophages (By similarity)

More Common Targets

EPX | EPYC | EQTN | ER Membrane Protein Complex | ERAL1 | ERAP1 | ERAP2 | ERAS | ERBB2 | ERBB3 | ERBB4 | ERBIN | ERC1 | ERC2 | ERC2-IT1 | ERCC1 | ERCC2 | ERCC3 | ERCC4 | ERCC5 | ERCC6 | ERCC6L | ERCC6L2 | ERCC6L2-AS1 | ERCC8 | EREG | ERF | ERFE | ERG | ERG28 | ERGIC1 | ERGIC2 | ERGIC3 | ERH | ERHP1 | ERI1 | ERI2 | ERI3 | ERICH1 | ERICH2 | ERICH3 | ERICH4 | ERICH5 | ERICH6 | ERICH6-AS1 | ERICH6B | ERLEC1 | ERLIN1 | ERLIN2 | ERLNC1 | ERMAP | ERMARD | ERMN | ERMP1 | ERN1 | ERN2 | ERO1A | ERO1B | ERP27 | ERP29 | ERP44 | ERRFI1 | ERV3-1 | ERVFRD-1 | ERVK-6 | ERVK13-1 | ERVMER34-1 | ERVV-1 | ERVV-2 | ERVW-1 | ESAM | ESAM-AS1 | ESCO1 | ESCO2 | ESCRT-0 complex | ESCRT-I complex | ESCRT-II complex | ESCRT-III complex | ESD | ESF1 | ESM1 | ESPL1 | ESPN | ESPNL | ESPNP | ESR1 | ESR2 | ESRG | ESRP1 | ESRP2 | ESRRA | ESRRB | ESRRG | ESS2 | Estrogen receptor | Estrogen-related receptor (ERR) (nonspecifed subtype) | ESX1 | ESYT1 | ESYT2 | ESYT3